MK-801 disrupts acquisition of contextual fear conditioning but enhances memory consolidation of cued fear conditioning

Behavioural Pharmacology

Volumn 13, Issue 4, 2002, Pages 287-294

  Gould, Thomas J ^a   McCarthy, M M ^a   Keith, R A ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

AMPA; Amygdala; Glutamate; Hippocampus; Learning; Memory; NMDA; Rat

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; DIZOCILPINE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; DOSE RESPONSE; FEAR; HIPPOCAMPUS; LEARNING; MALE; MEMORY CONSOLIDATION; NONHUMAN; RAT; SCORING SYSTEM;

EID: 0036637203     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200207000-00005     Document Type: Article

References (65)

1. Agmatine suppresses nitric oxide production in microglia
2. The NMDA antagonist MK-801 blocks the extinction of Pavlovian fear conditioning
3. Drugs detected in patients suspected of acute intoxication
4. 3H]MK-801 to brain regions and spinal cord of rats treated chronically with U-50,488H, a kappa-opioid receptor agonist
5. MK-801 potentiates morphine-induced impairment of memory consolidation in mice: Involvement of dopaminergic mechanisms
6. Substance abuse: Infant and childhood outcomes
7. Acquisition of contextual Pavlovian fear conditioning is blocked by application of an NMDA receptor antagonist D,L-2-amino-5-phosphonovaleric acid to the basolateral amygdala
8. Differential effects of selective opioid peptide antagonists on the acquisition of Pavlovian fear conditioning
9. Differential effects of the N-methyl-D-aspartate antagonist DL-2-amino-5-phosphonovalerate on acquisition of fear of auditory and contextual cues
10. NMDA and AMPA receptors in the lateral nucleus of the amygdala are postsynaptic to auditory thalamic afferents
11. Differential localization of NMDA and AMPA receptor subunits in the lateral and basal nuclei of the amygdala: A light and electron microscopic study
12. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro
13. Effects of a microinjection of morphine into the amygdala on the acquisition and expression of conditioned fear and hypoalgesia in rats
14. Nicotine enhancement of contextual fear conditioning
15. Learning impairments induced by glutamate blockade using dizocilpine (MK-801) in monkeys
16. MK-801 and AP5 impair acquisition, but not retention, of the Morris milk maze
17. Effects of naltrexone on learning and performance of conditional fear-induced freezing and opioid analgesia
18. Muscimol inactivation of the dorsal hippocampus impairs contextual retrieval of fear memory
19. Acquisition, extinction, and reinstatement of Pavlovian fear conditioning: The roles of the NMDA receptor and nitric oxide
20. Role of (+)-SKF-10,047-sensitive sub-population of sigma 1 receptors in amelioration of conditioned fear stress in rats: Association with mesolimbic dopaminergic systems
21. The specific N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 blocks U-50,488, but not morphine antinociception
22. N-methyl-D-aspartate receptor antagonist APV blocks acquisition but not expression of fear conditioning
23. Increased thresholds for long-term potentiation and contextual learning in mice lacking the NMDA-type glutamate receptor epsilon 1 subunit
24. Agmatine: An endogenous clonidine-displacing substance in the brain
25. NMDA and non-NMDA receptors contribute to synaptic transmission between the medial geniculate body and the lateral nucleus of the amygdala
26. Hippocampal lesions cause learning deficits in inbred mice in the Morris water maze and conditioned-fear task
27. Enhancement of contextual fear-conditioning by putative (+/-)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor modulators and N-methyl-D-aspartate (NMDA) receptor antagonists in DBA/2J mice
28. The nature and causes of hippocampal long-term potentiation
29. N-Methyl-D-aspartate receptor antagonism blocks contextual fear conditioning and differentially regulates early growth response-1 messenger RNA expression in the amygdala: Implications for a functional amygdaloid circuit of fear
30. Differential effects of NMDA antagonists microinjections into the nucleus reticularis pontis caudalis on seizures induced by pentylenetetrazol in the rat
31. N-methyl-D-aspartate receptors in the basolateral amygdala are required for both acquisition and expression of conditional fear in rats
32. Low dose of 1,3-di(2-tolyl)guanidine (DTG) attenuates MK-801-induced spatial working memory impairment in mice
33. MK-801 impedes the acquisition of a spatial memory task in rats
34. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats
35. Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex
36. Effects of MK-801, dantrolene, and FK506 on convulsive seizures and brain nitric oxide production in seizure-susceptible EL mice
37. Expression mechanisms underlying NMDA receptor-dependent long-term potentiation
38. Acute treatment with the N-methyl-D-aspartate receptor antagonist MK-801: Effect of concurrent administration of haloperidol or scopolamine on preproenkephalin mRNA levels of the striatum and nucleus accumbens of the rat brain
39. Intrahippocampal administration of (+)-SKF 10,047, a sigma ligand, reverses MK-801-induced impairment of working memory in rats
40. Posttraining injections of MK-801 produce a time-dependent impairment of memory in two water maze tasks
41. DBA/2 and C57BL/6 mice differ in contextual fear but not auditory fear conditioning
42. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning
43. Lesions of the dorsal hippocampal formation interfere with background but not foreground contextual fear conditioning
44. Lesions of the fornix but not the entorhinal or perirhinal cortex interfere with contextual fear conditioning
45. Fear conditioning enhances different temporal components of tone-evoked spike trains in auditory cortex and lateral amygdala
46. Agmatine, an endogenous ligand at imidazoline binding sites, does not antagonize the clonidine-mediated blood pressure reaction
47. Is agmatine a novel neurotransmitter in brain?
48. AMPA receptor facilitation accelerates fear learning without altering the level of conditioned fear acquired
49. Contextual conditioning and auditory cue conditioning dissociate during development
50. Isolation reduces contextual but not auditory-cue fear conditioning: A role for endogenous opioids
51. Suppression of inducible nitric oxide generation by agmatine aldehyde: Beneficial effects in sepsis
52. Antagonistic effects of the selective, competitive N-methyl-D-aspartate (NMDA) receptor antagonist, NPC 12626, on kappa opiate-induced analgesia in male deer mice
53. Hippocampus as a memory map: Synaptic plasticity and memory encoding by hippocampal neurons
54. Acquisition deficit and time-dependent retrograde amnesia for contextual fear conditioning in agmatine-treated rats
55. Genetic enhancement of learning and memory in mice
56. N-methyl-D-aspartate receptors in associative eyeblink conditioning: Both MK-801 and phencyclidine produce task- and dose-dependent impairments
57. The formalin test: An evaluation of the method
58. Preclinical evaluation of CHF3381 as a novel antiepileptic agent
59. 2- uptake and glutamate release in rat cerebral cortex in primary culture
60. Presynaptic changes during mossy fibre LTP revealed by NMDA receptor-mediated synaptic responses
61. L-type voltage-gated calcium channels mediate NMDA-independent associative long-term potentiation at thalamic input synapses to the amygdala
62. Microinjection of morphine into the nucleus accumbens impairs contextual learning in rats
63. Memantine in severe dementia: Results of the 9M-Best Study (benefit and efficacy in severely demented patients during treatment with memantine)
64. NMDA processes mediate anterograde amnesia of contextual fear conditioning induced by hippocampal damage: Immunization against amnesia by context preexposure
65. Sigma receptor ligands (+)-SKF 10,047 and SA4503 improve dizocilpine-induced spatial memory deficits in rats